News for Theratechnologies Inc. (THTX)

MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (”œTheratechnologies” or the ”œCompany”) (TSX: TH) ( THTX), a commercial-stage biophar

Theratechnologies Inc. (NASDAQ: THTX) held its virtual annual meeting of shareholders on May 29, 2025, electing eight directors to the Board. Shareholde

**media[640820]**

Summary:\n Theratechnologies (THTX) explores potential sale with active discussions ongoing. Analysts' price targets suggest a possible 46.62% stock upside

Theratechnologies Inc. (THTX) has announced a strategic move to explore the potential sale of the company, following a proposal from Future Pak. The decision wa

\n Theratechnologies (TSX: TH) (NASDAQ: THTX) is exploring a potential sale via an open and non-exclusive process. Engaged multiple advisors including Raym

**media[596154]**

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Monday. The Dow traded up 0.43% to 40,384.20 while t...

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 2% on Monday. The Dow traded up 0.99% to 40,610.00 while the NASDAQ gained 2.0...

U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Friday. Shares of Apple Inc. AAPL fell sharply in today's pre-ma...

Key Takeaways: Soleus Capital pushes for Theratechnologies Inc. to accept Future Pak's lucrative acquisition offer. Wall Street analysts forecast a subst

Key Highlights: Future Pak's proposed acquisition of Theratechnologies could increase the stock's value significantly. Analysts predict a 75.26% upside,

Shares of WaFd, Inc. WAFD rose sharply in today's pre-market trading following second-quarter results. WaFd posted quarterly GAAP EPS of 65 cents, beating mark...

Soleus Capital Management, a significant shareholder in Theratechnologies (THTX), has advocated for the company's board to consider a takeover proposal from Fut

Future Pak proposes an acquisition of Theratechnologies (THTX) at $3.51 per share, marking a 163% premium over the April 10th closing price. Soleus Capi

Soleus Capital Management, L.P. (”œSoleus Capital”), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ

MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (”œTheratechnologies” or the ”œCompany”) (TSX: TH) ( THTX), a commercial-stage bioph

Theratechnologies (THTX) stock gains as a new formulation of its best selling drug Egrifta is cleared by the FDA. Read more here.

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.